Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Biochim Biophys Acta Mol Cell Res ; 1866(12): 118516, 2019 12.
Article de Anglais | MEDLINE | ID: mdl-31348954

RÉSUMÉ

Actomyosin network under the plasma membrane of cells forms a cortical layer that regulates cellular deformations during different processes. What regulates the cortex? Characterized by its thickness, it is believed to be regulated by actin dynamics, filament-length regulators and myosin motor proteins. However, its regulation by cellular morphology (e.g. cell spread area) or mechanical microenvironment (e.g. substrate stiffness) has remained largely unexplored. In this study, super- and high-resolution imaging of actin in CHO cells demonstrates that at high spread areas (>450 µm2), the cortex is thinner, better separated as layers, and sensitive to deactivation of myosin II motors or reduction of substrate stiffness (and traction forces). In less spread cells (<400 µm2) such perturbations do not elicit a response. Myosin IIA's mechanosensing is limited here due to its lowered actin-bound fraction and higher turnover rate. Cofilin, in line with its competitive inhibitory role, is found to be overexpressed in these cells. To establish the causal relation, we initiate a spread area drop by de-adhesion and find enhanced actin dynamics and fragmentation along with oscillations and increase in thickness. This is more correlated to the reduction of traction forces than the endocytosis-based reduction in cell volume. Cortex thickness control by spread area is also found be true during differentiation of THP-1 monocytes to macrophages. Thus, we propose that spread area regulates cortex and its thickness by traction-based mechanosensing of myosin II.


Sujet(s)
Cortex cérébral/métabolisme , Myosine de type II/métabolisme , Animaux , Composés hétérocycliques bicycliques/pharmacologie , Cellules CHO , Adhérence cellulaire/effets des médicaments et des substances chimiques , Différenciation cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Cortex cérébral/effets des médicaments et des substances chimiques , Cricetulus , Cytochalasine D/pharmacologie , Humains , Myosine de type II/antagonistes et inhibiteurs , Cellules THP-1 , Thiazolidines/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...